2022
DOI: 10.1007/978-1-0716-2026-7_1
|View full text |Cite
|
Sign up to set email alerts
|

Cerebellar Modelling Using Human Induced Pluripotent Stem Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 34 publications
0
2
0
Order By: Relevance
“…Cerebellar organoid differentiation was performed as described previously. 9 In brief, human iPSC line AH017-3 cells 10 were detached by incubation with pre-warmed TrypLE for 5 minutes. Cells were collected by centrifugation and resuspended in induction medium (50% IMDM, 50% F12, 7ug/mL Insulin, 5mg/mL BSA, 1X Chemically defined Lipid concentrate, 450uM Monothioglycerol, 15ug/mL Apo-transferrin, 1X Penicillin/Streptomycin) at a final concentration of 100,000 cells/ml.…”
Section: Methodsmentioning
confidence: 99%
“…Cerebellar organoid differentiation was performed as described previously. 9 In brief, human iPSC line AH017-3 cells 10 were detached by incubation with pre-warmed TrypLE for 5 minutes. Cells were collected by centrifugation and resuspended in induction medium (50% IMDM, 50% F12, 7ug/mL Insulin, 5mg/mL BSA, 1X Chemically defined Lipid concentrate, 450uM Monothioglycerol, 15ug/mL Apo-transferrin, 1X Penicillin/Streptomycin) at a final concentration of 100,000 cells/ml.…”
Section: Methodsmentioning
confidence: 99%
“…Cerebellar organoids were generated as described (van Essen et al, 2022;Nayler et al, 2021;Watson et al, 2018). In brief, iPSC were detached using TrypLE™ Express Enzyme (1X) (Gibco™, Cat# 12604013) and resuspended in Induction Medium (50% Iscove's Modified Dulbecco's Medium (Gibco™, Cat# 31980022), 50% Ham's F-12 Nutrient Mix (Gibco™, Cat# 31765027), 7𝜇g/mL insulin (Sigma, Cat# I1882), 5mg/mL BSA (|Sigma, Cat# A3156-5G), 1% Chemically Defined Lipid Concentrate (Gibco™, Cat# 11905031), 450𝜇M 1-thioglycerol (Sigma, Cat# M-6145), 15𝜇g/mL apo-transferrin (Sigma, Cat# T1147), 1% Penicillin/Streptomycin (Gibco™, Cat#15140122)) containing 50µM Rho-kinase inhibitor(Abcam, Cat#ab120129) and 10µM SB431542 (Tocris, Cat#1614/10).…”
Section: Cerebellar Organoid Differentiationmentioning
confidence: 99%